المساهمون: Konstantinos N. Lazaridis, M.D., Hepatology Consultant

المصدر: Juran BD, Atkinson EJ, Schlicht EM, Larson JJ, Ellinghaus D, Franke A, Lazaridis KN. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis. Liver Int. 2011 Jul;31(6):785-91. doi: 10.1111/j.1478-3231.2010.02420.x. Epub 2010 Dec 7.
P.R.O.G.R.E.S.S.: PSC Resource Of Genetic Risk, Environment and Synergy Studies.

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01161992Test

المساهمون: Jayant A. Talwalkar, Principal Investigator

المصدر: Tabibian JH, Gossard A, El-Youssef M, Eaton JE, Petz J, Jorgensen R, Enders FB, Tabibian A, Lindor KD. Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis. Am J Ther. 2017 Jan/Feb;24(1):e56-e63. doi: 10.1097/MJT.0000000000000102.
A Pilot Study of Xifaxan in Patients With Primary Sclerosing Cholangitis

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01695174Test